Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0350
0.00 (0.00%)
Jan 30, 2026, 2:39 PM AEST
Immuron Market Cap
Immuron has a market cap or net worth of 11.39 million as of January 30, 2026. Its market cap has decreased by -30.95% in one year.
Market Cap
11.39M
Enterprise Value
5.64M
Revenue
7.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 11.39M, a decrease of -69.46%. That is a compound annual growth rate of -4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 11.39M | -2.78% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 23.38M |
| Neurotech International | 19.44M |
| Tissue Repair | 18.44M |
| AdAlta | 11.48M |
| Chimeric Therapeutics | 11.05M |
| Patrys | 10.22M |
| Biotron | 9.64M |
| Bio-Gene Technology | 9.15M |